Generex Awarded New Pain Relief Patents
Company Expands Patent Portfolio in Mexico and New Zealand
The patents share the title "Pharmaceutical Compositions for Buccal Delivery of Pain Relief Medications" and contain claims to a pharmaceutical composition for pain relief containing a narcotic analgesic in micellar form.
"We are pleased that our patent portfolio is expanding to include the pain relief application," said Rose Perri, the Company's Chief Operating Officer. "As we continue the pivotal Phase III studies of our flagship product, Generex Oral-lynT, we seek additional applications for our proprietary drug platform technology."
Generex currently holds an aggregate of 130 patents worldwide (21 of which are United States patents) and has an aggregate of 132 patent applications pending in various jurisdictions.
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.